Growth Metrics

Armata Pharmaceuticals (ARMP) Receivables: 2013-2017

Historic Receivables for Armata Pharmaceuticals (ARMP) over the last 2 years, with Mar 2017 value amounting to $15,000.

  • Armata Pharmaceuticals' Receivables rose 7.14% to $15,000 in Q1 2017 from the same period last year, while for Mar 2017 it was $69,000, marking a year-over-year decrease of 75.27%. This contributed to the annual value of $12,000 for FY2016, which is 90.40% down from last year.
  • According to the latest figures from Q1 2017, Armata Pharmaceuticals' Receivables is $15,000, which was up 25.00% from $12,000 recorded in Q4 2016.
  • Armata Pharmaceuticals' 5-year Receivables high stood at $136,000 for Q2 2014, and its period low was $8,000 during Q4 2013.
  • For the 3-year period, Armata Pharmaceuticals' Receivables averaged around $35,429, with its median value being $18,000 (2016).
  • In the last 5 years, Armata Pharmaceuticals' Receivables skyrocketed by 1,150.00% in 2014 and then tumbled by 90.40% in 2016.
  • Over the past 5 years, Armata Pharmaceuticals' Receivables (Quarterly) stood at $8,000 in 2013, then soared by 1,150.00% to $100,000 in 2014, then increased by 25.00% to $125,000 in 2015, then plummeted by 90.40% to $12,000 in 2016, then climbed by 7.14% to $15,000 in 2017.
  • Its last three reported values are $15,000 in Q1 2017, $12,000 for Q4 2016, and $24,000 during Q3 2016.